CIK 0000886163 · Large accelerated filer
LIGAND PHARMACEUTICALS INC
Sign in to watch- Tickers
- LGND LGNDZ LGNXZ LGNYZ LGNZZ
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 770160744
- Phone
- 858-550-7500
- Business address
- 3911 SORRENTO VALLEY BLVD, SUITE 110, SAN DIEGO, CA, 92121
- Former names
- LIGAND PHARMACEUTICALS
Securities
- LGND Common Stock Nasdaq
- LGNDZ Common stock OTC
- LGNXZ Common stock OTC
- LGNYZ Common stock OTC
- LGNZZ Common stock OTC
- 8-K Event Material agreement · Other events
- 4 Open-market sale Director sold 2,145 shares at $254.00 ($544,830)
- 144 Insider Sale of Securities
- 4 Open-market sale Director sold 6,461 shares at an average $255.58 ($1,651,320)
- 4 Open-market sale Director sold 5,000 shares at $250.00 ($1,250,000)
- 4 Open-market sale Director sold 4,591 shares at an average $250.88 ($1,151,774)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Shares withheld for taxes Director gave up 182 shares (to pay taxes)
- 4 Grant or award Director acquired 836 shares (grant or award)
- 4 Grant or award Director acquired 836 shares (grant or award)
- 4 Grant or award Director acquired 836 shares (grant or award)
- 4 Grant or award Director acquired 836 shares (grant or award)
- 4 Grant or award Director acquired 836 shares (grant or award)
- 8-K Event Executive or director change · Shareholder vote results
- 4 Planned sale CLO & Secretary sold 5,000 shares at an average $227.06 ($1,135,316)
- 4 Option exercise Chief Financial Officer acquired 1,736 shares (option exercise)
Page 3 of 115 · 2,300 filings